Novo Nordisk and Eli Lilly’s motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form complaint, however the defendants are saving their challenge to certain claims for later.
Novo Nordisk and Eli Lilly’s motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form complaint, however the defendants are saving their challenge to certain claims for later.
